NCT03460106 (SALMA) is a clinical trial in Asthma, sponsored by Heart of England NHS Trust.

Who is sponsoring NCT03460106?

NCT03460106 is sponsored by Heart of England NHS Trust.

Is NCT03460106 still recruiting?

NCT03460106 is currently status unknown. Last updated 11 February 2020.

Last reviewed 2020-02-11 · How we verify

NCT03460106: SALMA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Development of a Screening Assay by LC-MS/MS to Monitor Adherence to Asthma Treatment

Status unknown Last updated 11 February 2020

What this trial tests

trial in Asthma in 150 participants. Status unknown.

Timeline

3 April 2018

Primary endpoint
30 September 2020

30 September 2021

Quick facts

Lead sponsor	Heart of England NHS Trust
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	3 April 2018
Primary completion	30 September 2020
Estimated completion	30 September 2021
Sites	1 location across United Kingdom

Conditions studied

Asthma — all drugs for Asthma →

Sponsor

Heart of England NHS Trust

Who can join

Adults 18 to 80, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Phase I: To develop and validate laboratory urine and blood test for the detection of medications commonly used in the treatment of asthma Phase II: to test the developed assay in the clinic, to determine its practicality to conduct, and its clinical utility in adherence assessment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting

Other Heart of England NHS Trust trials

Trials by the same sponsor.

NCT03645733 — Evaluation of the Effect of Cooled Haemodialysis on Cognitive Function in Patients Suffering With End-stage KD · NA · unknown
NCT03482700 — Impact of Specialist Led Integrated Care in COPD · NA · unknown
NCT03069651 — Virtual Care in CF (VIRTUAL-CF) Study · NA · unknown
NCT02879773 — Computed Tomography Assessment of Regional Ventilation (CURVE) · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03460106 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Heart of England NHS Trust
Last refreshed: 11 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03460106.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing